No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival

Autor: Sucheston-Campbell, LE, Cannioto, R, Clay, AI, Etter, JL, Eng, KH, Liu, S, Battaglia, S, Hu, Q, Brian Szender, J, Minlikeeva, A, Joseph, JM, Mayor, P, Abrams, SI, Segal, BH, Wallace, PK, Soh, KT, Zsiros, E, Anton-Culver, H, Bandera, EV, Beckmann, MW, Berchuck, A, Bjorge, L, Bruegl, A, Campbell, IG, Campbell, SP, Chenevix-Trench, G, Cramer, DW, Mieszkowska, AD, Dao, F, Diergaarde, B, Doerk, T, Doherty, JA, Du Bois, A, Eccles, D, Engelholm, SA, Fasching, PA, Gayther, SA, Gentry-Maharaj, A, Glasspool, RM, Goodman, MT, Gronwald, J, Harter, P, Hein, A, Heitz, F, Hillemmanns, P, Høgdall, C, Høgdall, EVS, Huzarski, T, Jensen, A, Johnatty, SE, Jung, A, Karlan, BY, Klapdor, R, Kluz, T, Konopka, B, Kjer, SK, Kupryjanczyk, J, Lambrechts, D, Lester, J, Lubinski, J, Levine, DA, Lundvall, L, McGuire, V, McNeish, IA, Menon, U, Modugno, F, Ness, RB, Orsulic, S, Paul, J, Pearce, CL, Pejovic, T, Pharoah, P, Ramus, SJ, Rothstein, J, Rossing, MA, Rubner, M, Schildkraut, JM, Schmalfeldt, B, Schwaab, I, Siddiqui, N, Sieh, W

Publikováno v: Sucheston-Campbell, LE; Cannioto, R; Clay, AI; Etter, JL; Eng, KH; Liu, S; et al.(2017). No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology Biomarkers and Prevention, 26(3), 420-424. doi: 10.1158/1055-9965.EPI-16-0631. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/51z1w9zq

© 2016 American Association for Cancer Research. Background: The precise mechanism by which the immune system is adversely affected in cancer patients remains poorly understood, but the accumulation of immunosuppressive/protumorigenic myeloid-derive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::a63bbd5327726ba161d0022edf2f5d68
http://www.escholarship.org/uc/item/51z1w9zq

P53 mutations in tissue from Danish ovarian cancer patients From the Danish 'MALOVA' ovarian cancer study

Autor: Høgdall, EVS, Kjær, SK, Blaakær, Jan, Christensen, L, Glud, E, Høgdall, CK, Vuust, J

Publikováno v: Høgdall, EVS, Kjær, SK, Blaakær, J, Christensen, L, Glud, E, Høgdall, CK & Vuust, J 2005, ' P53 mutations in tissue from Danish ovarian cancer patients From the Danish "MALOVA" ovarian cancer study ', Gynecol Oncol. 2005 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::5a2b6669b0e767eb2fa8134b9b22e273
https://pure.au.dk/portal/da/publications/p53-mutations-in-tissue-from-danish-ovarian-cancer-patients-from-the-danish-malova-ovarian-cancer-study(3fca8080-ba40-11da-bee9-02004c4f4f50).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.